Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobukazu Fujimoto

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Journal for Immunotherapy of Cancer|February 27, 2020
Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesotheliomaKatsuyuki Hotta, Nobukazu Fujimoto
Scientific Reports|June 22, 2021
Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusionTakumi Kishimoto, Yoko Kojima, Nobukazu Fujimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
[Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma]Takumi Kishimoto, Nobukazu Fujimoto, Hideyuki Nishi
Respiratory Investigation|March 18, 2018
Clinical features of secondary spontaneous pneumothorax complicated with silicosisNorichika Iga, Hideyuki Nishi, Nobukazu Fujimoto, et al.
BMJ Case Reports|December 1, 2020
Nivolumab for malignant peritoneal mesotheliomaTakaaki Tanaka, Yosuke Miyamoto, Atsue Sakai, et al.
JTO Clinical and Research Reports|July 7, 2022
Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case ReportTakaaki Tanaka, Shoji Asakura, Kazuya Hisamatsu, et al.
BMJ Case Reports|February 5, 2021
Catamenial pneumothorax due to heterotopic endometriosis in the pericardiumYuki Takigawa, Daisuke Mizuno, Norichika Iga, et al.
BMJ Case Reports|July 21, 2023
Severe cardiotoxicity induced by osimertinib in a patient with EGFR-mutated adenocarcinoma of the lungTakaaki Tanaka, Soma Nii, Hidenaru Yamaoka, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance studyNobukazu Fujimoto, Ayumi Akamatsu, Chikara Honda, et al.
Journal of Occupational Health|December 14, 2020
Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklistTakumi Kishimoto, Nobukazu Fujimoto, Keiichi Mizuhashi, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|February 27, 2020
Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesotheliomaKatsuyuki Hotta, Nobukazu Fujimoto
Scientific Reports|June 22, 2021
Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusionTakumi Kishimoto, Yoko Kojima, Nobukazu Fujimoto
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 24, 2016
[Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma]Takumi Kishimoto, Nobukazu Fujimoto, Hideyuki Nishi
Respiratory Investigation|March 18, 2018
Clinical features of secondary spontaneous pneumothorax complicated with silicosisNorichika Iga, Hideyuki Nishi, Nobukazu Fujimoto, et al.
BMJ Case Reports|December 1, 2020
Nivolumab for malignant peritoneal mesotheliomaTakaaki Tanaka, Yosuke Miyamoto, Atsue Sakai, et al.
JTO Clinical and Research Reports|July 7, 2022
Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case ReportTakaaki Tanaka, Shoji Asakura, Kazuya Hisamatsu, et al.
BMJ Case Reports|February 5, 2021
Catamenial pneumothorax due to heterotopic endometriosis in the pericardiumYuki Takigawa, Daisuke Mizuno, Norichika Iga, et al.
BMJ Case Reports|July 21, 2023
Severe cardiotoxicity induced by osimertinib in a patient with EGFR-mutated adenocarcinoma of the lungTakaaki Tanaka, Soma Nii, Hidenaru Yamaoka, et al.
Japanese Journal of Clinical Oncology|September 3, 2024
Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance studyNobukazu Fujimoto, Ayumi Akamatsu, Chikara Honda, et al.
Journal of Occupational Health|December 14, 2020
Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklistTakumi Kishimoto, Nobukazu Fujimoto, Keiichi Mizuhashi, et al.
Pageof 11